Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.
about
Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profilingDysregulated expression of cell surface glycoprotein CDCP1 in prostate cancerAs a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma.CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
P2860
Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Loss of CDCP1 expression promo ...... ageal squamous cell carcinoma.
@en
type
label
Loss of CDCP1 expression promo ...... ageal squamous cell carcinoma.
@en
prefLabel
Loss of CDCP1 expression promo ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P50
P1476
Loss of CDCP1 expression promo ...... hageal squamous cell carcinoma
@en
P2093
Atsushi Niida
Genta Sawada
Hidenari Hirata
Hidetoshi Eguchi
Hiroki Ueo
Junji Kurashige
Keishi Sugimachi
Koshi Mimori
Masami Ueda
Ryutaro Uchi
P2860
P2888
P304
P356
10.1245/S10434-014-3740-4
P478
21 Suppl 4
P577
2014-05-22T00:00:00Z
P6179
1053676105